APLS MEXC RealStocks
Own real APLS shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 10:59:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Apellis Pharmaceuticals, Inc. (APLS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Apellis Pharmaceuticals, Inc. (APLS) is trading at $-- in pre-market trading as of --, -- from the previous close of $--
Pre-market trading shows how investors are pricing APLS before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, Apellis Pharmaceuticals, Inc. (APLS) moved from $40.95 to $41.03, representing a gain of 0.20% ($0.08).
The stock traded between $40.93 and $41.14 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 15.37 million shares, up versus the previous seven-day period, indicating higher trading activity.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Currently it has two marketed drugs that target C3, the central protein in the complement cascade: SYFOVRE (pegcetacoplan injection) and EMPAVELI (pegcetacoplan).
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 733 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Apellis Pharmaceuticals, Inc. (APLS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to APLS, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between APLS shares and USD.
APLS Shares to USD
1.00 APLS shares = 0 USD
Calculations are estimates based on the latest available price and are for reference only.